Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Dr. Christine Lovly is a Physician-Scientist at Vanderbilt Ingram Cancer Center, specializing in thoracic cancers. Dr. Lovly received her bachelor’s degree (BS) in Chemistry from Johns Hopkins University. As part of the Medical Scientist Training Program, Dr. Lovly went on to earn both her Medical Degree (MD) and doctoral degree (PhD) at Washington University in St. Louis, Missouri. She completed her internal medicine residency and medical oncology subspecialty at Vanderbilt University where she was named Chief Fellow. Dr. Lovly’s research is directed at the development of improved therapies for specific molecular subsets of lung cancer, and her clinical focus is primarily on the care of lung cancer patients. She is an active member in the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (IASLC), the American Association for Cancer Research (AACR), and the American Society of Clinical Investigators (ASCI). Dr. Lovly has authored multiple peer-reviewed scientific manuscripts and is also the co-editor for a Vanderbilt initiated website, www.mycancergenome.org, which provides healthcare practitioners, patients and patient advocates with up-to-date information on genetically informed cancer medicine. Dr. Lovly has served as a consultant for Pfizer, Novartis, Genoptix, Sequenom and Ariad and has been an invited speaker for Abbott and Qiagen.